Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, ...

Siren Biotechnology today announced the publication of its first peer-reviewed manuscript in Molecular Therapy Oncology, ...

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company, is seeking to raise as much as $212 million in a US ...

The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer ...

Building on landmark Nature Biotechnology findings, Nutromics secures AU$3 million in a AU$11.2 million consortium to ...

North Carolina’s milestone of exceeding $230 million in biomanufacturing workforce training investments marks an ...

Biobanks are huge repositories of biomedical data and biological samples, and most have been Western, so far. But China is ...

Governor Kay Ivey will participate in a grand opening ceremony for the Wiregrass Innovation Center in Downtown Dothan on ...

As part of this partnership, Mayo Clinic has made an equity investment in Sana Biotech, reflecting a shared goal of creating ...

Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defense, ...

Ligand Pharmaceuticals will buy fellow biotechnology royalty aggregator XOMA Royalty for about $739 million in cash, the companies said on Monday. The ​deal adds more than 120 treatments, including ...

An armed intruder is believed to have stolen a truck from bioMérieux's Hazelwood campus; police are investigating.